Skip to content
NVR/TKI

Drawing based on the description in the official product monograph. No photo yet.

“A red imprint is stamped on each capsule ("NVR/TKI")”

NVR/TKI pill

Pill with imprint NVR/TKI is red, capsule and has been identified as Nilotinib Hydrochloride Monohydrate 200 mg. It is used for accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors. It is supplied by Novartis Pharmaceuticals Canada Inc.

Sold in Canada

Nilotinib Hydrochloride Monohydrate 200 mg

Brand
Tasigna
Imprint
NVR/TKI
Strength
200 mg
Used for
Accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors
Color
Red
Shape
Capsule / oblong
Form
Capsule
Manufacturer
Novartis Pharmaceuticals Canada Inc
Drug class
Cancer medicine (kinase inhibitor)
Sold in
Canada
DIN
02315874

Source: Health Canada's Drug Product Database and the official product monograph. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Nilotinib pills and guides

What is Nilotinib used for?

Nilotinib is used for accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors.

Medicine type
Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label

Adult Patients With Newly Diagnosed Ph+ CML-CP

Nilotinib Capsules is indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase.

Additional pediatric use information is approved for Novartis Pharmaceuticals Corporation’s Tasigna ® (nilotinib) capsules. However, due to Novartis Pharmaceuticals Corporation’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.

Adult Patients With Resistant or Intolerant Ph+ CML-CP and CML-AP

Nilotinib Capsules is indicated for the treatment of adult patients with chronic phase and accelerated phase Philadelphia chromosome positive chronic myelogenous leukemia (Ph+ CML) resistant or intolerant to prior therapy that included imatinib.

Additional pediatric use information is approved for Novartis Pharmaceuticals Corporation’s Tasigna ® (nilotinib) capsules. However, due to Novartis Pharmaceuticals Corporation’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.

From the FDA-approved label on DailyMed (published Sep 30, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows NVR/TKI.
  • It is red, capsule.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold in Canada as Tasigna by Novartis Pharmaceuticals Canada Inc.

In Canada: prescription only.

Ingredients

Active: Nilotinib (Nilotinib Hydrochloride Monohydrate)

Other pills with imprint NVR TKI

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Nilotinib pills